Publication 2014

  • Sakiyama M, Matsuo H, Takada Y, Nakamura T, Nakayama A, Takada T, Kitajiri SI, Wakai K, Suzuki H, Shinomiya N. Ethnic Differences in ATP-binding Cassette Transporter, Sub-Family G, Member 2 (ABCG2/BCRP): Genotype Combinations and Estimated Functions. Drug Metab Pharmacokinet. 2014 29(6):490-492. [abstract]
  • Sakiyama M, Matsuo H, Shimizu S, Nakashima H, Nakayama A, Chiba T, Naito M, Takada T, Suzuki H, Hamajima N, Ichida K, Shimizu T, Shinomiya N. A Common Variant of Organic Anion Transporter 4 (OAT4/SLC22A11) Gene Is Associated with Renal Underexcretion Type Gout. Drug Metab Pharmacokinet. 2014 29(2):208-210. [abstract]
  • Sakiyama M, Matsuo H, Shimizu S, Chiba T, Nakayama A, Takada Y, Nakamura T, Takada T, Morita E, Naito M, Wakai K, Inoue H, Tatsukawa S, Sato J, Shimono K, Makino T, Satoh T, Suzuki H, Kanai Y, Hamajima N, Sakurai Y, Ichida K, Shimizu T, Shinomiya N. A common variant of leucine-rich repeat-containing 16A (LRRC16A) gene is associated with gout susceptibility. Hum Cell 2014 27(1):1-4. [abstract]
  • Ohno Y, Yamada M, Yamaguchi R, Hisaka A, Suzuki H. Persistent drug interaction between aprepitant and warfarin in patients receiving anticancer chemotherapy. Int J Clin Pharm. 2014 36(6):1134-1137. [abstract]
  • Ito N, Ito K, Ikebuchi Y, Kito T, Miyata H, Toyoda Y, Tappei T, Hisaka A, Honma M, Oka A, Kusuhara H, Suzuki H. Organic cation transporter/solute carrier family 22a is involved in drug transfer into milk in mice. J Pharm Sci. 2014 103(10):3342-3348. [abstract]
  • Hisaka A, Nakamura M, Tsukihashi A, Koh S, Suzuki H.  Assessment of Intestinal Availability (FG) of Substrate Drugs of Cytochrome P450s by Analyzing Changes in Pharmacokinetic Properties Caused by Drug-Drug Interactions. Drug Metab Dispos. 2014 42(10):1640-1645. [abstract]
  • Abe T, Yanagihara Y, Uchino T, Oriyama T, Komatsu M, Nakajima K, Suzuki H. Evaluation of the Pharmaceutical Characteristics of Various Enteric-Coated Aspirin Tablets under Different Storage Conditions. Chem Pharm Bull. 2014 62(7):617–626. [abstract]

  • Nakayama A, Matsuo H, Nakaoka H, Nakamura T, Nakashima H, Takada Y, Oikawa Y, Takada T, Sakiyama M, Shimizu S, Kawamura Y, Chiba T, Abe J, Wakai K, Kawai S, Okada R, Tamura T, Shichijo Y, Akashi A, Suzuki H, Hosoya T, Sakurai Y, Ichida K, Shinomiya N. Common dysfunctional variants of ABCG2 have stronger impact on hyperuricemia progression than typical environmental risk factors.  Sci Rep. 2014 4:5227. [abstract] [プレスリリース]

  • Panthee N, Ono M, Morota T, Tanaka T, Itoda Y, Ikemura M, Yamamoto T, Suzuki H, Saito A, Motomura N.  Paraplegia prevention by oral pretreatment with memantine in a rabbit model. J Thorac Cardiovasc Surg. 2014 148(4):1732-1738. [abstract]

  • Suzuki S, Shuto T, Sato T, Kaneko M, Takada T, Suico MA, Cyr DM, Suzuki H, Kai H. Inhibition of post-translational N-glycosylation by HRD1 that controls the fate of ABCG5/8 transporter.  Sci Rep. 2014 4:4258. [abstract]

  • Honma M, Ikebuchi Y, Kariya Y, Suzuki H. Regulatory Mechanisms of RANKL Presentation to Osteoclast Precursors. Curr Osteoporos Rep. 2014 12(1):115-120. [abstract]

  • Matsuo H, Nakayama A, Sakiyama M, Chiba T, Shimizu S, Kawamura Y, Nakashima H, Nakamura T, Takada Y, Oikawa Y, Takada T, Nakaoka H, Abe J, Inoue H, Wakai K, Kawai S, Guang Y, Nakagawa H, Ito T, Niwa K, Yamamoto K, Sakurai Y, Suzuki H, Hosoya T, Ichida K, Shimizu T, Shinomiya N. ABCG2 dysfunction causes hyperuricemia due to both renal urate underexcretion and renal urate overload.  Sci Rep. 2014 4:3755. [abstract] [プレスリリース]